
CVS Health (CVS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $2.09 | $1.64 | 27.4 % |
| Q2 | Aug 5, 2026 | $2.58 | $1.84 | 40.2 % |
| Q1 | May 6, 2026 | $2.57 | $2.21 | 16.3 % |
| Q4 | Feb 10, 2026 | $1.09 | $0.99 | 10.1 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $108.40B | $104.76B | 3.47 % |
| Q2 | Aug 5, 2026 | $106.10B | $100.09B | 6.00 % |
| Q1 | May 6, 2026 | $100.43B | $94.89B | 5.84 % |
| Q4 | Feb 10, 2026 | $105.69B | $103.52B | 2.10 % |
CVS Health (CVS) last issued guidance on November 4, 2026 for fiscal year 2026. The company guided revenue in the range of for the period.
Compared to prior guidance, CVS Health raised its EPS outlook from a previous range of $7.3 - $7.5.
CVS Health has issued 23 guidance updates between January 9, 2023 and August 5, 2026. During this period, the company raised its outlook 7 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.64 | $1.84 | $2.21 | $0.99 |
| Actual | $2.09 | $2.58 | $2.57 | $1.09 |
| Surprise | +27.4% | +40.2% | +16.3% | +10.1% |
| Revenue | ||||
| Estimate | $104.76B | $100.09B | $94.89B | $103.52B |
| Actual | $108.40B | $106.10B | $100.43B | $105.69B |
| Surprise | +3.47% | +6.00% | +5.84% | +2.10% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.04 | $2.75 | $2.67 | $1.96 |
| Revenue | ||||
| Consensus | $107.62B | $102.45B | — | — |